A.R.T. Advisors’s AstraZeneca AZN Stock Holding History

A.R.T. Advisors’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-15,050	Closed	-$1.5M	–	136
2019 Q4	$1.5M	Buy	+15,050	New	+$1.42M	0.07%	406
2018 Q2	–	Sell	-70,300	Closed	-$4.92M	–	1415
2018 Q1	$4.92M	Buy	70,300 +65,400	+1,335%	+$4.53M	0.2%	103
2017 Q4	$340K	Buy	+4,900	New	+$330K	0.02%	1025
2017 Q3	–	Sell	-35,750	Closed	-$2.44M	–	1357
2017 Q2	$2.44M	Buy	35,750 +21,200	+146%	+$1.38M	0.13%	220
2017 Q1	$906K	Buy	+14,550	New	+$847K	0.04%	592
2015 Q2	–	Sell	-34,329	Closed	-$2.35M	–	1476
2015 Q1	$2.35M	Sell	34,329 -27,376	-44%	-$1.9M	0.08%	334
2014 Q4	$4.34M	Buy	61,705 +48,167	+356%	+$3.45M	0.16%	157
2014 Q3	$967K	Buy	+13,538	New	+$991K	0.04%	516

Other funds holding AZN

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

A.R.T. Advisors's AZN Position: Q1 2020 in Review

A.R.T. Advisors sold out of AstraZeneca (AZN) in Q1 2020, closing a stake of 15,050 shares — an estimated $1.5M sold.

A.R.T. Advisors first reported a position in AZN in Q3 2014 and held it in 8 quarters. The position peaked at $4.92M in Q1 2018. 603 funds tracked by Wall St. Rank hold AZN as of Q1 2020.

A.R.T. Advisors reported no remaining AstraZeneca position as of Q1 2020 after selling out during the quarter.
A.R.T. Advisors sold 15,050 AstraZeneca shares in Q1 2020, an estimated $1.5M.
A.R.T. Advisors first reported a position in AstraZeneca in Q3 2014 and held it in 8 quarters.
A.R.T. Advisors's AstraZeneca position peaked at $4.92M in Q1 2018.
603 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2020.

Based on A.R.T. Advisors's 13F filing for Q1 2020, filed 15 May 2020.